ATLANTA, GA / ACCESSWIRE / November 21, 2022 / Holzer & Holzer, LLC is investigating whether Treace Medical Concepts, Inc. ('Treace Medical' or the 'Company') (NASDAQ:TMCI) complied with federal securities laws. On November 15, 2022, Culper Research published a report alleging Treace Medical has driven its business through 'aggressive reimbursement practices and deceptive [direct to consumer] marketing.' Culper Research's report claims that the Company sells its Lapiplasty kit for the treatment of bunions at 'multiples higher' than traditional kits and justifies the costs through 'dubious billing tactics such as unnecessary complexity adjustments, unbundling, and billing for procedures which simply never happened.' Following this report, the Company's stock price dropped.

If you purchased Treace Medical stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at  [email protected]  or Joshua Karr, Esq. at [email protected], call our toll-free number at (888) 508-6832, or visit our website at https://holzerlaw.com/case/treace-medical/  to discuss your legal rights.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content. 

CONTACT: 

Corey Holzer, Esq.
(888) 508-6832 (toll-free) 
[email protected]

SOURCE: Holzer & Holzer, LLC